Christopher Knox, DO
Otolaryngology · Rochester, NHNPI 1760547418
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (58.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Aerin Medical Inc. at 46.1% of the total. Reporting peaked in 2023 at $1,350 and has fallen 98.8% since, to $17 in 2025. Among otolaryngology clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 30 payments — averaging $94.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$1K
- Smith+Nephew$881
- Intersect ENT, Inc.$437
- Stryker$97
- Sanofi$46
- Regeneron Healthcare Solutions, Inc.$43
- plus $25 from 1 others
What the payments were for
- Consulting fees$753%
- Travel & lodging$1,65158%
- Food & beverage$1,11139%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 13 | $1,307 |
| Smith+Nephew | 3 | $881 |
| Intersect ENT, Inc. | 6 | $437 |
| Stryker | 3 | $97 |
| Sanofi | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 2 | $43 |
| Optinose US, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$851
- Coblation$804
- TULA$804
- PROPEL$283
How this compares
$2,837 in reported general payments places this provider in the 90th percentile of 44 otolaryngology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 180 | $4,243 |
| Fluticasone Propionate | 132 | $1,818 |
| Azelastine Hcl | 35 | $1,136 |
| Fluocinolone Acetonide Oil | 23 | $1,059 |
| Mometasone Furoate | 12 | $491 |
| Amitriptyline Hcl | 16 | $465 |
| Famotidine | 50 | $447 |
| Dexamethasone Sodium Phosphate | 11 | $378 |
| Mupirocin | 12 | $80 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $73 |
| Prednisone | 24 | $53 |
| Omeprazole | 25 | $31 |
| Montelukast Sodium | 11 | $19 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Rochester
- James BartelsManchester$5K
- Joseph PaydarfarLebanon$5K
- Michael ToscanoDover$4K
- Taraneh AzarPortsmouth$4K
- Avery NelsonKeene$2K
- Keith JorgensenDerry$2K
- Ross JohnstonLebanon$2K
- Carly SchrageLaconia$2K
- Angela DamianoKeene$2K
- Sarah SeoLebanon$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.